This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baquero, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baquero, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 1999, p. 357-359, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Antimicrobial Resistance of 1,113 Streptococcus pneumoniae Isolates from Patients with Respiratory Tract Infections in Spain: Results of a 1-Year (1996-1997) Multicenter Surveillance Study

Fernando Baquero,1 José Angel García-Rodríguez,2 Juan García de Lomas,3 Lorenzo Aguilar,4,* and The Spanish Surveillance Group for Respiratory Pathogensdagger

Microbiology Department, Ramón y Cajal Hospital,1 and Medical Department, SmithKline Beecham Pharmaceuticals,4 Madrid, Microbiology Department, University Hospital, Salamanca,2 and Instituto Valenciano de Microbiología, Valencia,3 Spain

Received 22 May 1998/Returned for modification 7 August 1998/Accepted 12 November 1998

A nationwide susceptibility surveillance of 1,113 Streptococcus pneumoniae isolates was carried out and found the following percentages of resistance: cefuroxime, 46%; penicillin, 37%; macrolides, 33%; aminopenicillins, 24%; cefotaxime, 13%; and ceftriaxone, 8%. A significant (P < 0.05) seasonality pattern for beta -lactam antibiotics was observed. Resistance to macrolides was higher (P < 0.05) in middle-ear samples. Higher percentages of resistance to cefuroxime and macrolides were observed among penicillin-intermediate and -resistant strains, whereas high frequencies of resistance to aminopenicillins and expanded-spectrum cephalosporins were observed only among penicillin-resistant strains.


* Corresponding author. Mailing address: Departamento Médico, SmithKline Beecham Pharmaceuticals, Valle de la Fuenfría, 3, 28034 Madrid, Spain. Phone: 34-91-3345275. Fax: 34-91-3345141. E-mail: lorenzo.aguilar-alfaro{at}sb.com.

dagger The members of the Spanish Surveillance Group for Respiratory Pathogens are T. Jiménez de Anta and F. Marco, Clinic i Provincial Hospital, Barcelona; E. Bouza and E. Cercenado, Gregorio Marañón Hospital, Madrid; R. Gómez-Lus and M. C. Rubio, University Hospital, Zaragoza; M. Gobernado and N. Diosdado, La Fe Hospital, Valencia; I. Trujillano, University Hospital, Salamanca; C. García Riestra and I. Rodríguez, Xeral de Galicia Hospital, Santiago de Compostela; M. de la Rosa and A. Martínez-Brocal, Virgen de las Nieves Hospital, Granada; A. Gutierrez and A. García, La Paz Hospital, Madrid; A. M. Martín Sánchez and F. Cañas, Insular Hospital, Las Palmas; E. Perea and L. Martínez, Virgen Macarena Hospital, Seville; G. Prats and F. Sanchez, Santa Creu i San Pau Hospital, Barcelona; M. Casal and A. Ibarra, Reina Sofia Hospital, Córdoba; R. Cisterna and A. Morla, Basurto Hospital, Bilbao; A. C. Gómez-García and F. J. Blanco-Palenciano, Infanta Cristina Hospital, Badajoz; C. Gimeno and D. Navarro, Instituto Valenciano de Microbiología, Valencia; and A. Torrellas, J. J. Granizo, R. Moreno, and R. Dal-Ré, SmithKline Beecham Pharmaceuticals, Madrid.


Antimicrobial Agents and Chemotherapy, February 1999, p. 357-359, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Garvey, M. I., Piddock, L. J. V. (2008). The Efflux Pump Inhibitor Reserpine Selects Multidrug-Resistant Streptococcus pneumoniae Strains That Overexpress the ABC Transporters PatA and PatB. Antimicrob. Agents Chemother. 52: 1677-1685 [Abstract] [Full Text]  
  • Sevillano, D., Aguilar, L., Alou, L., Gimenez, M.-J., Echevarria, O., Cafini, F., Valero, E., Fenoll, A., Prieto, J. (2006). Effects of antimicrobials on the competitive growth of Streptococcus pneumoniae: a pharmacodynamic in vitro model approach to selection of resistant populations. J Antimicrob Chemother 58: 794-801 [Abstract] [Full Text]  
  • Siquier, B., Sanchez-Alvarez, J., Garcia-Mendez, E., Sabria, M., Santos, J., Pallares, R., Twynholm, M., Dal-Re, R., on behalf of the 620 Clinical Study Group, (2006). Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 57: 536-545 [Abstract] [Full Text]  
  • Nunes, S., Sa-Leao, R., Carrico, J., Alves, C. R., Mato, R., Avo, A. B., Saldanha, J., Almeida, J. S., Sanches, I. S., de Lencastre, H. (2005). Trends in Drug Resistance, Serotypes, and Molecular Types of Streptococcus pneumoniae Colonizing Preschool-Age Children Attending Day Care Centers in Lisbon, Portugal: a Summary of 4 Years of Annual Surveillance. J. Clin. Microbiol. 43: 1285-1293 [Abstract] [Full Text]  
  • Fernandez, A., Cabellos, C., Tubau, F., Maiques, J. M., Domenech, A., Ribes, S., Linares, J., Viladrich, P. F., Gudiol, F. (2005). Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. J Antimicrob Chemother 55: 78-83 [Abstract] [Full Text]  
  • Oteo, J., Lazaro, E., de Abajo, F. J., Baquero, F., Campos, J., Spanish Members of the European Antimicrobial Resi, (2004). Trends in Antimicrobial Resistance in 1,968 Invasive Streptococcus pneumoniae Strains Isolated in Spanish Hospitals (2001 to 2003): Decreasing Penicillin Resistance in Children's Isolates. J. Clin. Microbiol. 42: 5571-5577 [Abstract] [Full Text]  
  • Canton, R., Morosini, M., Enright, M. C., Morrissey, I. (2003). Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. J Antimicrob Chemother 52: 944-952 [Abstract] [Full Text]  
  • Reynolds, R., Shackcloth, J., Felmingham, D., MacGowan, A., on behalf of the BSAC Extended Working Party on Re, (2003). Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme. J Antimicrob Chemother 52: 931-943 [Abstract] [Full Text]  
  • Mason, E. O. Jr., Lamberth, L. B., Wald, E. R., Bradley, J. S., Barson, W. J., Kaplan, S. L. (2003). In Vitro Activities of Cethromycin (ABT-773), a New Ketolide, against Streptococcus pneumoniae Strains That Are Not Susceptible to Penicillin or Macrolides. Antimicrob. Agents Chemother. 47: 166-169 [Abstract] [Full Text]  
  • Bogaert, D., Ha, N. T., Sluijter, M., Lemmens, N., de Groot, R., Hermans, P. W. M. (2002). Molecular Epidemiology of Pneumococcal Carriage among Children with Upper Respiratory Tract Infections in Hanoi, Vietnam. J. Clin. Microbiol. 40: 3903-3908 [Abstract] [Full Text]  
  • Perez-Trallero, E., Garcia-Rey, C., Martin-Sanchez, A. M., Aguilar, L., Garcia-de-Lomas, J., Ruiz, J. (2002). Activities of Six Different Quinolones against Clinical Respiratory Isolates of Streptococcus pneumoniae with Reduced Susceptibility to Ciprofloxacin in Spain. Antimicrob. Agents Chemother. 46: 2665-2667 [Abstract] [Full Text]  
  • Casal, J., Aguilar, L., Jado, I., Yuste, J., Gimenez, M. J., Prieto, J., Fenoll, A. (2002). Effects of Specific Antibodies against Streptococcus pneumoniae on Pharmacodynamic Parameters of {beta}-Lactams in a Mouse Sepsis Model. Antimicrob. Agents Chemother. 46: 1340-1344 [Abstract] [Full Text]  
  • Del Grosso, M., Iannelli, F., Messina, C., Santagati, M., Petrosillo, N., Stefani, S., Pozzi, G., Pantosti, A. (2002). Macrolide Efflux Genes mef(A) and mef(E) Are Carried by Different Genetic Elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40: 774-778 [Abstract] [Full Text]  
  • Balcabao, I. P., Alou, L., Aguilar, L., Gomez-Lus, M. L., Gimenez, M. J., Prieto, J. (2001). Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones. J Antimicrob Chemother 48: 907-909 [Abstract] [Full Text]  
  • Perez-Trallero, E., Fernandez-Mazarrasa, C., Garcia-Rey, C., Bouza, E., Aguilar, L., Garcia-de-Lomas, J., Baquero, F., The Spanish Surveillance Group for Respiratory Pat, (2001). Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998-1999) Multicenter Surveillance Study in Spain. Antimicrob. Agents Chemother. 45: 3334-3340 [Abstract] [Full Text]  
  • Alou, L., Ramirez, M., Garcia-Rey, C., Prieto, J., de Lencastre, H. (2001). Streptococcus pneumoniae Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Clonal Diversity and Appearance of Ciprofloxacin-Resistant Epidemic Clones. Antimicrob. Agents Chemother. 45: 2955-2957 [Abstract] [Full Text]  
  • de Neeling, A. J., Overbeek, B. P., Horrevorts, A. M., Ligtvoet, E. E. J., Goettsch, W. G. (2001). Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999. J Antimicrob Chemother 48: 441-444 [Abstract] [Full Text]  
  • Morosini, M.-I., Canton, R., Loza, E., Negri, M.-C., Galan, J.-C., Almaraz, F., Baquero, F. (2001). In Vitro Activity of Telithromycin against Spanish Streptococcus pneumoniae Isolates with Characterized Macrolide Resistance Mechanisms. Antimicrob. Agents Chemother. 45: 2427-2431 [Abstract] [Full Text]  
  • Bogaert, D., Engelen, M. N., Timmers-Reker, A. J. M., Elzenaar, K. P., Peerbooms, P. G. H., Coutinho, R. A., de Groot, R., Hermans, P. W. M. (2001). Pneumococcal Carriage in Children in The Netherlands: a Molecular Epidemiological Study. J. Clin. Microbiol. 39: 3316-3320 [Abstract] [Full Text]  
  • Hoban, D. J., Wierzbowski, A. K., Nichol, K., Zhanel, G. G. (2001). Macrolide-Resistant Streptococcus pneumoniae in Canada during 1998-1999: Prevalence of mef(A) and erm(B) and Susceptibilities to Ketolides. Antimicrob. Agents Chemother. 45: 2147-2150 [Abstract] [Full Text]  
  • Fitoussi, F., Loukil, C., Gros, I., Clermont, O., Mariani, P., Bonacorsi, S., Le Thomas, I., Deforche, D., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in France. Antimicrob. Agents Chemother. 45: 1889-1891 [Abstract] [Full Text]  
  • Garcia-Garrote, F., Cercenado, E., Martin-Pedroviejo, J., Cuevas, O., Bouza, E. (2001). Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens. J Antimicrob Chemother 47: 681-684 [Abstract] [Full Text]  
  • Sahm, D. F., Karlowsky, J. A., Kelly, L. J., Critchley, I. A., Jones, M. E., Thornsberry, C., Mauriz, Y., Kahn, J. (2001). Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis. Antimicrob. Agents Chemother. 45: 1037-1042 [Abstract] [Full Text]  
  • Fitoussi, F., Doit, C., Geslin, P., Brahimi, N., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France. Antimicrob. Agents Chemother. 45: 636-638 [Abstract] [Full Text]  
  • Oteo, J., Alos, J. I., Gomez-Garces, J. L. (2001). Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: a multicentre surveillance study. J Antimicrob Chemother 47: 215-218 [Abstract] [Full Text]  
  • Syrogiannopoulos, G. A., Grivea, I. N., Tait-Kamradt, A., Katopodis, G. D., Beratis, N. G., Sutcliffe, J., Appelbaum, P. C., Davies, T. A. (2001). Identification of an erm(A) Erythromycin Resistance Methylase Gene in Streptococcus pneumoniae Isolated in Greece. Antimicrob. Agents Chemother. 45: 342-344 [Abstract] [Full Text]  
  • García-Rey, C., Aguilar, L., Baquero, F., Spanish Surveillance Group for Respiratory Pathoge, (2000). Influences of Different Factors on Prevalence of Ciprofloxacin Resistance in Streptococcus pneumoniae in Spain. Antimicrob. Agents Chemother. 44: 3481-3482 [Full Text]  
  • Bogaert, D., Syrogiannopoulos, G. A., Grivea, I. N., de Groot, R., Beratis, N. G., Hermans, P. W. M. (2000). Molecular Epidemiology of Penicillin-Nonsusceptible Streptococcus pneumoniae among Children in Greece. J. Clin. Microbiol. 38: 4361-4366 [Abstract] [Full Text]  
  • Granizo, J. J., Aguilar, L., Casal, J., Garcia-Rey, C., Dal-Re, R., Baquero, F. (2000). Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and {beta}-lactam consumption in Spain (1979-1997). J Antimicrob Chemother 46: 767-773 [Abstract] [Full Text]  
  • Marco, F., Bouza, E., Garcia-de-Lomas, J., Aguilar, L. (2000). Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. J Antimicrob Chemother 46: 557-564 [Abstract] [Full Text]  
  • Betriu, C., Redondo, M., Palau, M. L., Sánchez, A., Gómez, M., Culebras, E., Boloix, A., Picazo, J. J. (2000). Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci. Antimicrob. Agents Chemother. 44: 1838-1841 [Abstract] [Full Text]  
  • Hsueh, P.-R., Liu, Y.-C., Shyr, J.-M., Wu, T.-L., Yan, J.-J., Wu, J.-J., Leu, H.-S., Chuang, Y.-C., Yeu-Jen Lau, , Luh, K.-T. (2000). Multicenter Surveillance of Antimicrobial Resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 Respiratory Season. Antimicrob. Agents Chemother. 44: 1342-1345 [Abstract] [Full Text]  
  • Heaton, V. J., Goldsmith, C. E., Ambler, J. E., Fisher, L. M. (1999). Activity of Gemifloxacin against Penicillin- and Ciprofloxacin-Resistant Streptococcus pneumoniae Displaying Topoisomerase- and Efflux-Mediated Resistance Mechanisms. Antimicrob. Agents Chemother. 43: 2998-3000 [Abstract] [Full Text]  
  • Oster, P., Zanchi, A., Cresti, S., Lattanzi, M., Montagnani, F., Cellesi, C., Rossolini, G. M. (1999). Patterns of Macrolide Resistance Determinants among Community-Acquired Streptococcus pneumoniae Isolates over a 5-Year Period of Decreased Macrolide Susceptibility Rates. Antimicrob. Agents Chemother. 43: 2510-2512 [Abstract] [Full Text]  
  • Gómez-Lus, R., Granizo, J. J., Aguilar, L., Bouza, E., Gutierrez, A., García-de-Lomas, J., Spanish Surveillance Group for Respiratory Pathoge, (1999). Is There an Ecological Relationship between Rates of Antibiotic Resistance of Species of the Genus Streptococcus?. J. Clin. Microbiol. 37: 3384-3386 [Abstract] [Full Text]